TYVASO Trademark

Trademark Overview

On Wednesday, March 19, 2008, a trademark application was filed for TYVASO with the United States Patent and Trademark Office. The USPTO has given the TYVASO trademark a serial number of 77425786. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, December 20, 2019. This trademark is owned by Lung Rx, Inc.. The TYVASO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension
tyvaso

General Information

Serial Number77425786
Word MarkTYVASO
Filing DateWednesday, March 19, 2008
Status800 - REGISTERED AND RENEWED
Status DateFriday, December 20, 2019
Registration Number3709561
Registration DateTuesday, November 10, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 24, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for inhalation for the treatment of pulmonary hypertension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 25, 2008
Primary Code005
First Use Anywhere DateWednesday, September 2, 2009
First Use In Commerce DateWednesday, September 2, 2009

Trademark Owner History

Party NameUNITED THERAPEUTICS CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSILVER SPRING, MD 20910
Party NameLung Rx, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
Party NameLung Rx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910
Party NameLung Rx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSilver Spring, MD 20910

Trademark Events

Event DateEvent Description
Friday, December 20, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, December 20, 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, December 20, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, December 20, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 6, 2019TEAS SECTION 8 & 9 RECEIVED
Saturday, November 10, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, January 12, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, January 12, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, January 8, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 4, 2015TEAS SECTION 8 & 15 RECEIVED
Wednesday, June 9, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 10, 2009REGISTERED-PRINCIPAL REGISTER
Thursday, October 8, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, October 6, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 22, 2009STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 3, 2009USE AMENDMENT FILED
Tuesday, September 22, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 3, 2009TEAS STATEMENT OF USE RECEIVED
Thursday, March 12, 2009EXTENSION 1 GRANTED
Thursday, March 12, 2009EXTENSION 1 FILED
Thursday, March 12, 2009TEAS EXTENSION RECEIVED
Tuesday, September 16, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 24, 2008PUBLISHED FOR OPPOSITION
Wednesday, June 4, 2008NOTICE OF PUBLICATION
Wednesday, May 21, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 21, 2008ASSIGNED TO LIE
Wednesday, May 21, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 21, 2008ASSIGNED TO EXAMINER
Tuesday, March 25, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

tyvaso pulmonary hypertension treatment inhalation preparations pharmaceutical